5/17
11:07 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
4/11
12:17 pm
carm
Rating for CARM
Low
Report
Rating for CARM
4/11
08:00 am
carm
Carisma Therapeutics, Inc. (NASDAQ: CARM) is now covered by analysts at BTIG Research. They set a "buy" rating and a $6.00 price target on the stock.
Low
Report
Carisma Therapeutics, Inc. (NASDAQ: CARM) is now covered by analysts at BTIG Research. They set a "buy" rating and a $6.00 price target on the stock.